Breaking News
Tuesday , October 17 2017
Home / Tag Archives: Gilead Sciences

Tag Archives: Gilead Sciences

Natco Pharma launches Hepatitis C drug Velpanat in India

Natco Pharma has launched a generic version of sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination in India. Sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination is sold by Gilead Sciences, globally, under the brand name Epclusa. Epclusa is the first all-oral, pan-genotypic, single tablet regimen ... Read More »